<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Exhibit 99.1</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="ex99-1_001.jpg" alt=""></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 10pt"><b>Cuprina Holdings
(Cayman) Limited Announces Pricing of $12 million Initial Public Offering</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>SINGAPORE, April 10, 2025</b> &ndash; Cuprina Holdings
(Cayman) Limited (&ldquo;<b>CUPR</b>&rdquo; or &ldquo;the <b>Company</b>&rdquo;), a biomedical and biotechnology company dedicated to
the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty
sector, today announced the pricing of its firm commitment initial public offering of an aggregate 3,000,000 shares of its Class A Ordinary
Shares (&ldquo;the <b>Offering</b>&rdquo;), all of which are being offered by CUPR at a public offering price of $4.00 per share (&ldquo;<b>the
Offering Price</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has granted the underwriter a 45-day option
to purchase up to an additional 450,000 shares of its Class A Ordinary Shares at the Offering Price, representing 15% of the Class A Ordinary
Shares sold in the Offering (&ldquo;the <b>Over-allotment</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assuming that the Over-allotment is exercised, the
Company is expected to receive gross proceeds amounting to $13.80 million, before deducting underwriting discounts and commissions and
estimated offering expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares are expected to begin trading on the NASDAQ
Stock Market LLC under the ticker symbol &ldquo;CUPR&rdquo; on April 10, 2025. The Offering is expected to close on April 11, 2025, subject
to the satisfaction of customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">R. F. Lafferty &amp; Co., Inc. (&ldquo;<b>R. F. Lafferty</b>&rdquo;)<font style="background-color: white">,</font>
acted as the sole book-running manager for the Offering. Loeb &amp; Loeb LLP, Lee &amp; Lee, Harney Westwood &amp; Riegels Singapore LLP
are acting as U.S., Singapore and Cayman Islands legal counsels to the Company, respectively, and Winston &amp; Strawn LLP is acting as
U.S. legal counsel to R. F. Lafferty for the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Offering is being conducted pursuant to the Company&rsquo;s
Registration Statement on Form F-1 (File No: 333-283643) previously filed with and subsequently declared effective by the U.S. Securities
and Exchange Commission (&ldquo;<b>SEC</b>&rdquo;) on March 31, 2025. The Offering is being made only by means of a prospectus. Before
you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about
the Company and the Offering. Copies of the final prospectus related to the Offering may be obtained, when available, from R. F. Lafferty
&amp; Co., Inc., 40 Wall Street, 27th Floor, New York, NY 10005; (212) 293-9090, or by email at offerings@rflafferty.com. In addition,
a copy of the final prospectus, when available, relating to the Offering may be obtained via the SEC&rsquo;s website at www.sec.gov.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release has been prepared for informational
purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company&rsquo;s securities,
nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor
shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>FORWARD-LOOKING STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain statements contained in this press release
about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute
&ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation Reform Act of 1995. These statements
include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo;
&ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;target,&rdquo;
&ldquo;will,&rdquo; &ldquo;would&rdquo; and similar expressions are intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking
statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the
public offering on the anticipated terms or at all, and other factors discussed in the &ldquo;Risk Factors&rdquo; section of the preliminary
prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking
statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and
Cuprina Holdings (Cayman) Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of
new information, future events or otherwise, except as required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>About Cuprina Holdings (Cayman) Limited</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are a Singapore-based biomedical and biotechnology
company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well
as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived
from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information,
please visit https:// www.cuprina.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Cuprina Holdings (Cayman) Limited Investor Contact<br />
</b>Investor Relations<br />
c/o Blk 1090 Lower Delta Road #06-08<br />
Singapore 169201<br />
+65 8512 7275<br />
Email:&nbsp;ir@cuprina.com.sg</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Investor Relations Inquiries:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Skyline Corporate Communications Group, LLC</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Scott Powell, President</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">1177 Avenue of the Americas, 5<sup>th</sup> Floor</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">New York, New York 10036</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Office: (646) 893-5835</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Email: info@skylineccg.com</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
